Munger Mode rating: 2 out of 5 — Sell. Our own rating from the research report below, on business quality first: moat durability and management, with price separating the top three.
Price used: about $91 (closed $89.90 on Nov 2, about $91.90 the next morning after the fiscal Q1 report). 52-week range: roughly $79–$129. Market cap is about $11B on 121.1M shares. We looked at Clorox the way we look at everything. First, is it a wonderful business? Second, is management excellent? Third, is the price low enough to forgive any shortfall on the first two? Clorox is a good, durable, but no longer wonderful business. It has strong brands in midsized categories and a first-rate distribution position at Walmart and other mass retailers. Over the last five years, though, it has shown it cannot reliably turn that position into rising owner earnings. Margins collapsed and only partly recovered. The ERP transition botched shipments. The company borrowed about $2.1B for the GOJO deal while its common equity went negative. The dividend consumes most of reported earnings.
Recent filings analysed: 8-K (2026-11-19), 10-Q (2026-11-02), 8-K (2026-11-02), 8-K (2026-10-29).
Stock screener · Superinvestor 13F holdings · Analyst sentiment